Fingerprinting the circulating repertoire of antibodies from cancer patients

Recognition of molecular diversity in disease is required for the development of targeted therapies. We have developed a screening method based on phage display to select peptides recognized by the repertoire of circulating tumor-associated antibodies. Here we isolated peptides recognized by antibodies purified from the serum of prostate cancer patients. We identified a consensus motif, NXS/TDKS/T, that bound selectively to circulating antibodies from cancer patients over control antibodies from blood donors. We validated this motif by showing that positive serum reactivity to the peptide was specifically linked to disease progression and to shorter survival in a large patient population. Moreover, we identified the corresponding protein eliciting the immune response. Finally, we showed a strong and specific positive correlation between serum reactivity to the tumor antigen, development of metastatic androgen-independent disease, and shorter overall survival. Exploiting the differential humoral response to cancer through such an approach may identify molecular markers and targets for diagnostic and therapeutic intervention.

[1]  J. Natvig,et al.  Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library , 1993, European journal of immunology.

[2]  A. Meola,et al.  Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library. , 1994, Gene.

[3]  R. King,et al.  Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue. , 1996, British journal of urology.

[4]  M. Sioud,et al.  Profiling the immune response in patients with breast cancer by phage‐displayed cDNA libraries , 2001, European journal of immunology.

[5]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[6]  P. Srivastava,et al.  Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. , 1998, Immunity.

[7]  Y. Argon,et al.  Molecular chaperones and the biosynthesis of antigen receptors. , 1995, Immunology today.

[8]  A. Giaccia,et al.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.

[9]  A. Fauci,et al.  Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. , 1999, Journal of immunology.

[10]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[11]  H. Jörnvall,et al.  Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry , 2001, Cellular and Molecular Life Sciences CMLS.

[12]  J. Whisstock,et al.  Prediction of the Immunodominant Epitope of the Pyruvate Dehydrogenase Complex E2 in Primary Biliary Cirrhosis Using Phage Display , 2000, The Journal of Immunology.

[13]  B. Polla,,et al.  Hsp70--a multi-gene, multi-structure, multi-function family with potential clinical applications. , 1994, Experientia.

[14]  Myron Tanncnbaum,et al.  Urologic pathology: The prostate , 1977 .

[15]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[16]  R. Cortese,et al.  Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes. , 1996, Journal of autoimmunity.

[17]  P. Srivastava,et al.  Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. , 1997, Science.

[18]  J. Trapani,et al.  A fresh look at tumor immunosurveillance and immunotherapy , 2001, Nature Immunology.

[19]  L. Buhl,et al.  Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia , 2002, British journal of haematology.

[20]  Yao-Tseng Chen.  Cancer vaccine: identification of human tumor antigens by SEREX. , 2000, Cancer journal.

[21]  V. Petrenko,et al.  Identifying Diagnostic Peptides for Lyme Disease through Epitope Discovery , 2001, Clinical Diagnostic Laboratory Immunology.

[22]  J. Davies,et al.  A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen–human IgE antibody interaction , 2001, FEBS letters.

[23]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[24]  A. Meola,et al.  Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. , 1996, Journal of immunology.

[25]  N. Bolton,et al.  Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands , 1983, The Prostate.

[26]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[27]  R. Crameri,et al.  Direct selection of cDNAs by phage display. , 2002, Methods in molecular biology.

[28]  G. P. Smith,et al.  Libraries of peptides and proteins displayed on filamentous phage. , 1993, Methods in enzymology.

[29]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .

[30]  Wadih Arap,et al.  Biopanning and rapid analysis of selective interactive ligands , 2001, Nature Medicine.

[31]  Anna Tramontano,et al.  Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants , 1998, The EMBO journal.

[32]  H. Schulz.  [The TNM classification of pancreas cancer]. , 1988, Archiv fur Geschwulstforschung.

[33]  L. Old,et al.  Cancer Tumor antigens. , 1997, Current opinion in immunology.

[34]  F. Schröder,et al.  The TNM classification of prostate cancer , 1992, The Prostate. Supplement.

[35]  B. Polla,,et al.  Heat shock proteins: the hsp70 family , 1994, Experientia.

[36]  Heimo Breiteneder,et al.  Allergen mimotopes for 3‐dimensional epitope search and induction of antibodies inhibiting human IgE , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  D. Fradelizi,et al.  Major histocompatibility class one molecule associates with glucose regulated protein (GRP) 78 on the cell surface. , 2001, Human immunology.

[38]  M. Pfreundschuh,et al.  Serological analysis of human tumor antigens: molecular definition and implications. , 1997, Molecular medicine today.

[39]  Carlos F. Barbas,et al.  Phage display: a Laboratory manual , 2014 .

[40]  K. Brown,et al.  New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries. , 2000, Current opinion in chemical biology.

[41]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[42]  G. Damonte,et al.  Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells , 2000, Nature Medicine.

[43]  R. Tafi,et al.  Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Pfreundschuh,et al.  Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Senju,et al.  Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. , 2001, Biochemical and biophysical research communications.

[46]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[47]  D. Fradelizi,et al.  GRP78, a Coreceptor for Coxsackievirus A9, Interacts with Major Histocompatibility Complex Class I Molecules Which Mediate Virus Internalization , 2002, Journal of Virology.

[48]  R Pasqualini,et al.  Molecular addresses in blood vessels as targets for therapy. , 2001, Current opinion in chemical biology.

[49]  Amy S. Lee,et al.  The glucose-regulated proteins: stress induction and clinical applications. , 2001, Trends in biochemical sciences.